Is BMRA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for BMRA. It does not provide personalized investment advice.

BMRA (BIOMERICA INC) Stock Analysis - Financials

BIOMERICA INC (BMRA) is a publicly traded Healthcare sector company. As of August 26, 2026, BMRA trades at $1.78 with a market cap of $5.47M and a P/E ratio of -0.69. BMRA moved +0.00% today. Year to date, BMRA is -33.21%; over the trailing twelve months it is -48.64%. Its 52-week range spans $1.45 to $10.16. Rallies surfaces BMRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are BMRA's key financials?

BMRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BMRA recently traded at $1.78. Market cap is $5.47M. P/E ratio is -0.69. Revenue is $4.46M.

BMRA Key Metrics

Key financial metrics for BMRA
Metric	Value
Price	$1.78
Market Cap	$5.47M
P/E Ratio	-0.69
EPS	$-2.52
Dividend Yield	0.00%
52-Week High	$10.16
52-Week Low	$1.45
Volume	5.24K
Avg Volume	0
Revenue (TTM)	$4.46M
Net Income	$-4.03M
Gross Margin	5.65%

BMRA Analyst Consensus

BMRA analyst coverage data. Average price target: $0.00.

Common questions about BMRA

What are BMRA's key financials?: BMRA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. BMRA recently traded at $1.78. Market cap is $5.47M. P/E ratio is -0.69. Revenue is $4.46M.
Is BMRA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for BMRA. It does not provide personalized investment advice.